CD8A and neoplasm: The pivotal enzyme of the TCA cycle, pyruvate dehydrogenase in CD8 + T lymphocytes, is targeted by pharmacological agents to preserve their functionality in the hypoxic conditions of the tumor microenvironment characterized by lactic acid buildup [125].